Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Kulkarni Samarth | Dec 2, 2024 | Sell | 15,000 | $55.1043 | $830,000 |
| KASINGER JAMES R. | Oct 14, 2024 | Sell | 1,089 | $46.28 | $50,000 |
| Kulkarni Samarth | Oct 14, 2024 | Sell | 4,293 | $46.28 | $200,000 |
| Bruno Julianne | Jun 21, 2024 | Sell | 3,366 | $56.09 | $190,000 |
| Kulkarni Samarth | Apr 15, 2024 | Sell | 18,378 | $59.8819 | $1.1M |
| Kulkarni Samarth | Apr 15, 2024 | Sell | 1,204 | $60.4003 | $73,000 |
| Kulkarni Samarth | Mar 15, 2024 | Sell | 10,613 | $71.9693 | $760,000 |
| Prasad Raju | Mar 15, 2024 | Sell | 3,524 | $72.69 | $260,000 |
| Kulkarni Samarth | Mar 15, 2024 | Sell | 9,387 | $73.0604 | $690,000 |
| KASINGER JAMES R. | Mar 12, 2024 | Sell | 1,146 | $74.44 | $85,000 |
| Kulkarni Samarth | Mar 12, 2024 | Sell | 4,583 | $74.44 | $340,000 |
| KASINGER JAMES R. | Mar 11, 2024 | Sell | 2,801 | $78.26 | $220,000 |
| Kulkarni Samarth | Mar 11, 2024 | Sell | 9,802 | $78.26 | $770,000 |
| KASINGER JAMES R. | Feb 20, 2024 | Sell | 1,913 | $79.67 | $150,000 |
| Kulkarni Samarth | Feb 20, 2024 | Sell | 6,370 | $79.67 | $510,000 |
| Kulkarni Samarth | Feb 15, 2024 | Sell | 12,949 | $79.9359 | $1M |
| Kulkarni Samarth | Feb 15, 2024 | Sell | 5,951 | $81.0379 | $480,000 |
| Kulkarni Samarth | Feb 15, 2024 | Sell | 1,100 | $81.6645 | $90,000 |
| Kulkarni Samarth | Jan 29, 2024 | Sell | 49,300 | $60.5031 | $3M |
| Kulkarni Samarth | Jan 29, 2024 | Sell | 700 | $61.0998 | $43,000 |
| Kulkarni Samarth | Jan 16, 2024 | Sell | 20,000 | $62.5029 | $1.3M |
| Kulkarni Samarth | May 30, 2023 | Sell | 9,300 | $65.63 | $610,000 |
| Kulkarni Samarth | May 30, 2023 | Sell | 7,301 | $63.6149 | $460,000 |
| Kulkarni Samarth | May 30, 2023 | Sell | 5,999 | $64.4577 | $390,000 |
| Kulkarni Samarth | May 30, 2023 | Sell | 2,400 | $66.8338 | $160,000 |
| Kulkarni Samarth | Apr 25, 2023 | Sell | 20,607 | $50.4982 | $1M |
| Kulkarni Samarth | Apr 25, 2023 | Sell | 4,393 | $51.4503 | $230,000 |
| Kulkarni Samarth | Mar 29, 2023 | Sell | 19,719 | $44.3733 | $870,000 |
| Kulkarni Samarth | Mar 29, 2023 | Sell | 5,281 | $44.7844 | $240,000 |
| Kulkarni Samarth | Feb 27, 2023 | Sell | 13,720 | $48.5725 | $670,000 |
| Kulkarni Samarth | Feb 27, 2023 | Sell | 10,180 | $47.7122 | $490,000 |
| Kulkarni Samarth | Feb 27, 2023 | Sell | 1,100 | $49.1986 | $54,000 |
| Kulkarni Samarth | Jan 27, 2023 | Sell | 23,200 | $51.5393 | $1.2M |
| Kulkarni Samarth | Jan 27, 2023 | Sell | 1,800 | $50.6032 | $91,000 |
| Kulkarni Samarth | Dec 28, 2022 | Sell | 20,366 | $40.8126 | $830,000 |
| Kulkarni Samarth | Dec 28, 2022 | Sell | 4,634 | $41.4546 | $190,000 |
What's the latest insider transaction for Crispr Therapeutics?
The most recent insider transaction for Crispr Therapeutics was conducted by Kulkarni Samarth, who sold 15,000 shares on December 2, 2024 at a price of $55.10 per share.
Which insider has sold the most CRSP stock over the last two years?
Kulkarni Samarth has sold the most CRSP stock in the last 2 years, with a total value of $19M.
What is the total value of insider transactions for Crispr Therapeutics (CRSP) in the last 2 years?
The total value of insider transactions for Crispr Therapeutics in the last 2 years is negative, amounting to -$20M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Crispr Therapeutics' market confidence?
Over the last 2 years, insider transactions for Crispr Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
